NCT07748468Not yet recruiting
Impact of Antioxidant-rich Supplementation on Skin Carotenoids Status, Antioxidant Status and Cardiometabolic Health in Overweight and Obese Individuals
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
This study aims to evaluate the effects of antioxidant-rich supplementation on skin carotenoid status, antioxidant status, and cardiometabolic health in overweight and obese individuals. The study may provide additional scientific evidence to support the further refinement of current dietary and nutritional recommendations.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 83 (estimated)
- First submitted
- 15 May 2026
- Start date
- 15 Aug 2026
- Primary completion date
- 1 Aug 2027
- Lead sponsor
- National University of Singapore
- Diseases
- Obesity
- NCT number
- NCT07748468
What you commit to
- Study type: Interventional
- Planned participants: 83
- From 15 Aug 2026 to the primary completion date, 1 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking medications or dietary supplements which may impact eye/skin health
- Taking lipid-lowering and blood pressure controlling medications less than 3 years
Other
- Weight change \> 3kg in the past 3 months
- Exercising vigorously over the past 3 months
- Smoking
- Drinking more than 2 alcoholic drinks per day
- Pregnant, lactating, or planning pregnancy in the next 6 months
Who the study is looking for
- Able to give informed consent (AMT score ≥ 8 for older adults \[65-70 years old\])
- Adults 21-70 years old
- English-literate
- Have venous access sufficient to allow for blood sampling as per the protocol
- No drastic change of diet for the past 1 year
- If taking medication, has been consistently taking antihypertensive/cholesterol-lowering/type-2 diabetic medication for more than 3 years prior to starting the study
Age in the registry: 21 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NUS, Department of Food Science and Technology, 1 Science Drive 3, Block S13, #03-07, Singapore, 117550 Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.